Raman chemical mapping reveals site of action of HIV protease inhibitors in HPV16 E6 expressing cervical carcinoma cells

DH Kim, RM Jarvis, JW Allwood, G Batman… - Analytical and …, 2010 - Springer
It has been shown that the HIV protease inhibitors indinavir and lopinavir may have activity
against the human papilloma virus (HPV) type 16 inhibiting HPV E6-mediated proteasomal …

[HTML][HTML] Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base

J Jhaveri, L Rayfield, Y Liu, M Chowdhary… - Journal of …, 2017 - ncbi.nlm.nih.gov
Background To examine the prognostic relevance of human papillomavirus (HPV) infection
for anal squamous cell carcinoma (ASCC) patients treated with chemoradiation (CRT) in the …

ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma

Z Bai, Y Wang, H Zhe, J He, P Hai - Radiation oncology, 2012 - Springer
Background The purpose of this study was to investigate whether the excision repair cross-
complementation group 1 (ERCC1) mRNA expression could predict treatment response of …

Tumor epression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma

P Silva, CM West, N Slevin, H Valentine… - International Journal of …, 2007 - Elsevier
Purpose: Vaults are multi-subunit structures that may be involved in nucleo-cytoplasmic
transport, with the major vault protein (MVP or lung resistance-related protein [LRP]) being …

HPV Status and individual characteristics of human papillomavirus infection as predictors for clinical outcome of locally advanced cervical cancer

L Mkrtchian, I Zamulaeva, L Krikunova… - Journal of Personalized …, 2021 - mdpi.com
This study is aimed at searching for an informative predictor of the clinical outcome of
cervical cancer (CC) patients. The study included 135 patients with locally advanced …

Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora A

HJ Shin, JY Kim, L Hampson, H Pyo… - … journal of radiation …, 2010 - Taylor & Francis
Purpose: To examine the effect of the human papillomavirus (HPV) type 16-E6 (HPV
'early'gene) oncoprotein on in vitro radiosensitivity of HPV-negative/p53 mutant C33a …

Cidofovir induces an increase in levels of low‐risk and high‐risk HPV E6

AJ Donne, L Hampson, XT He… - Head & Neck …, 2009 - Wiley Online Library
Background. Cidofovir is a nucleoside analogue that is used off‐license to treat recurrent
respiratory papillomatosis (RRP) caused by HPV6/11. However, the effect of this drug upon …

The transcriptional regulator gene E2 of the Human Papillomavirus (HPV) 16 influences the radiosensitivity of cervical keratinocytes

K Lindel, S Rieken, S Daffinger, KJ Weber… - Radiation …, 2012 - Springer
Background Clinical studies have demonstrated that HPV induced tumors constitute a
specific subclass of cancer with a better response to radiation treatment. The purpose of this …

Survival benefits of human papillomavirus 16 infection in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy: A retrospective cohort …

F Qu, C Ji, Y Wang, R Zhu, W Hu, S Liu… - Journal of Medical …, 2024 - Wiley Online Library
The role of human papillomavirus 16 (HPV 16) in esophageal squamous cell carcinoma
(ESCC) remains uncertain. Therefore, this study aimed to investigate the prevalence of HPV …

The roles of excision repair cross-complementation group1 in objective response after cisplatin-based concurrent chemoradiotherapy and survival in head and neck …

Y Gao, D Liu - Oral Oncology, 2015 - Elsevier
Our aim of the study was to investigate the precise relationship of repair cross-
complementation group 1 (ERCC1) expression and the survival as well as objective …